Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
129 hedge funds and large institutions have $407M invested in Flexion Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 17 closing their positions.
45% more call options, than puts
Call options by funds: $2.61M | Put options by funds: $1.8M
38% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 34
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
0% more funds holding
Funds holding: 129 → 129 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $426M → $407M (-$19.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$8.57M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
+$7.38M |
| 3 |
CC
Clearline Capital
New York
|
+$4.08M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$2.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$17.9M |
| 2 |
BAMCO Inc
New York
|
-$8.42M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$6.02M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$4.32M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.06M |
FLXN Hedge Fund Activity: Q2 2019 in Review
129 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q2 2019, worth a combined $407M — down 4.5% from $426M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new FLXN positions and 17 closed out — a net gain of 2 holders — while 47 added to existing stakes and 34 trimmed.
The largest buyer was Miller Value Partners, adding an estimated $8.57M. The largest seller was Pictet Asset Management (UK), exiting entirely with an estimated $17.9M sold.
- 129 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $407M of Flexion Therapeutics, Inc. stock for Q2 2019, down 4.5% quarter-over-quarter.
- 19 funds opened new Flexion Therapeutics, Inc. positions in Q2 2019 and 17 closed out, a net change of +2 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q2 2019 was Miller Value Partners, an estimated $8.57M added.
- The largest Flexion Therapeutics, Inc. seller in Q2 2019 was Pictet Asset Management (UK), an estimated $17.9M sold.
Based on aggregated 13F filings for Q2 2019.